CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Biopolitical Times

What might have been the story of the year turned out to be a disappointment. On February 14th, the National Academies delivered a valentine to those who want to commit germline gene editing. Its much anticipated report, Human Genome Editing: Science, Ethics, and Governance concluded that scientists should “proceed with caution.” This was the first time that human germline modification has ever been given a green light by a comparable body – the U.S. National Academies is an influential non-governmental...

Op-Ed

New evidence shows that the tests many companies use to determine a woman's chances of having a baby are based on bogus science.

"Learn how many high quality eggs you have remaining and your chances of getting pregnant now and...

Biopolitical Times

Last January, CGS predicted that gene editing would be one of the biggest science stories of the year. This has...

Op-Ed

For more than a decade, Canadian regulation has explicitly countered commercialization of reproduction, prohibiting payment for surrogacy, sperm, or eggs...

Biopolitical Times

Last January, CGS predicted that gene editing would be one of the biggest science stories of the year. This has...

Abby Lippman, friend and colleague to the Center for Genetics and Society and myriad other social justice organizations, died on...

Personal DNA tests, marketed directly to consumers with promises of revealing health and ancestry information, were a much-recommended gift this...

News

Aggregated News

Malis* sits under her home in a remote village with her legs folded under her swelling belly. She’s six months pregnant, expecting a baby girl, and knows nothing about the child’s parents except that they are Chinese.

She also is...

Aggregated News

Gene editing can change an animal’s sex.

A graduate student was waiting for Alison Van Eenennaam in the doorway of her lab at the University of California, Davis. An Australian geneticist, she spends days on the road arguing with critics...

Aggregated News

Researchers hoping to use a gene-editing technique to treat diseases may have to seek alternative enzymes.

The body’s own immune system could thwart some efforts to develop gene therapies based on the trendy genome-editing tool called CRISPR-Cas9, according to...

Aggregated News

Regeneron Pharmaceuticals Inc on Monday announced a collaboration with rival drugmakers that will speed its effort to collect genetic information on 500,000 people in the UK Biobank database, a project it believes could help accelerate new drug discovery and improve...

Video

Talking Biopolitics 2017-2018 with Shobita Parthasarathy and Tania Simoncelli
Talking Biopolitics 2017-2018 with Ben Hurlbut and Patricia Williams
Gene Editing and the Future of Reproductive Justice